News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Offering Of Common Stock



7/30/2014 10:35:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NYSE MKT: TXMD) (the “Company”) announced today the pricing of an underwritten public offering of approximately 8.6 million shares of its common stock, offered at a price of $4.67 per share. The gross proceeds to the Company from this offering are expected to be approximately $40.0 million, before deducting underwriting discounts, commissions and other estimated offering expenses payable by the Company. All of the shares in the offering are to be sold by the Company. In addition, the Company has granted the underwriters an option for a period of 30 days to purchase, at the public offering price less the underwriting discount, up to approximately 1.3 million additional shares of its common stock. The offering is expected to close on or about August 4, 2014, subject to the satisfaction of customary closing conditions.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES